Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Organon & Co. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 610 | 6 | 636 | +32 |
| Shares | 199.8M | 166.8K | 218.6M | +19.0M (+9.5%) |
| Value | $1.20B | $998.6K | $2.92B | +$1.73B (+144.2%) |
6 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (122)
Institutions that held Organon & Co. at the end of Q2 2026 but not at the end of Q1 2026.
Showing the largest 100 of 122 by value.
Sold out (90)
Institutions that held Organon & Co. at the end of Q1 2026 and filed for Q2 2026 without it.
Not filed for Q2 2026 yet (6)
Institutions that held Organon & Co. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 115,640 | $692.1K |
| CWM, LLC | 50,836 | $304.5K |
| McIlrath & Eck, LLC | 264 | $1.58K |
| Horizons Wealth Management | 42 | $252 |
| Evelyn Partners Investment Management (Europe) Ltd | 23 | $138 |
| Sunbelt Securities, Inc. | 5 | $29 |